Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Becker Drapkin Management Increases Its Holding of Cascade Microtech, Inc. (CSCD)

Matthew Drapkin and Steven R. Becker, the managers of Becker Drapkin Management are optimistic about the prospects of Cascade Microtech, Inc. (NASDAQ:CSCD). According to a recent filing with the Securities and Exchange Commission, Becker Drapkin Management has increased its holding of the stock by 212,885 shares to a total of 1,179,921 shares, which account for 7.3% of the company’s common stock. Given the current price of $8.99, Becker Drapkin’s stake has a value in excess of $10.6 million.


Jim Simons, the renowned hedge fund guru, is also a fan of Cascade Microtech, Inc. (NASDAQ:CSCD). During the fourth quarter of 2013, his fund, Renaissance Technologies, upped its stake in the company by 59% to 529,700 shares, reportedly worth $4.93 million. Israel Englander is also bullish on this stock, with Millennium Management initiating a new position, which contains 41,085 shares as at the end of 2013.

Cascade Microtech, Inc. (NASDAQ:CSCD) engages in the production of probing solutions for semiconductor testing processes. It has a market cap of $145 million and does not pay a dividend. The stock is traded at a trailing Price to Earnings (P/E) ratio of 10.10, significantly lower than the industry average of 38.60. For the three months ending December 31, 2013, Cascade posted revenues of $34 million and earnings per share (EPS) of $0.56. For the current quarter the company is expected to register revenues of $32.5 million and earnings of $0.13 per share. The stock is touted as a strong buy with a price target of $11 per share.

Drapkin and Becker are particularly bullish on Comverse Inc(NASDAQ:CNSI), a provider of software and system solutions for businesses. During the last quarter of 2013, Becker Drapkin Management increased their stake by a massive 1347% taking their holding to 1.35 million shares valued at $52.3 million. Another important change was the 142% increase in Becker Drapkin’s investment in EMCORE Corporation (NASDAQ:EMKR). The fund currently holds 3.19 million shares valued at $16.3 million.

Disclosure: none

Recommended reading:

Kevin Kotler’s Broadfin Capital Reports New Stake In MELA Sciences Inc (MELA)

Springbok Capital’s Top Picks: General Motors Company (GM) and Constellium NV (CSTM)

Stephen Mandel’s Lone Pine Discloses 6.4% Stake in SouFun Holdings (SFUN)

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!